Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Barnett

Showing results (261-270 of 409) with videos related to

Pageof 41
Sort By:
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Profile of select hepatic insulin signaling pathway genes in response to 2-aminoanthracene dietary ingestionN D Mattis, J W Jay, G W Barnett, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
The Journal of Biological Chemistry|November 25, 1982
Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activityD A Eppstein, Y V March, B B Schryver, et al.
Virology|June 15, 2007
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogensNina R Derby, Sean Gray, Elizabeth Wayner, et al.
Journal of Virology|February 23, 2000
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag geneJ zur Megede, M C Chen, B Doe, et al.
Journal of Virology|August 17, 2006
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infectionNina R Derby, Zane Kraft, Elaine Kan, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Journal of Virology|August 14, 2003
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?Tulio de Oliveira, Susan Engelbrecht, Estrelita Janse van Rensburg, et al.
Talanta|July 1, 2008
A screening test for heroin based on sequential injection analysis with dual-reagent chemiluminescence detectionLauren A Hill, Claire E Lenehan, Paul S Francis, et al.
Chemical Biology & Drug Design|February 18, 2009
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexesArmando G Villaseñor, Rama Kondru, Hoangdung Ho, et al.
Pageof 41

Showing results (261-270 of 409) with videos related to

Sort By:
Pageof 41
Journal of Biological Regulators and Homeostatic Agents|January 27, 2015
Profile of select hepatic insulin signaling pathway genes in response to 2-aminoanthracene dietary ingestionN D Mattis, J W Jay, G W Barnett, et al.
Journal of Virology|May 14, 2003
Expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 subtype B pol and gagpol DNA vaccinesJan zur Megede, Gillis R Otten, Barbara Doe, et al.
The Journal of Biological Chemistry|November 25, 1982
Analogs of (A2'p)nA. Correlation of structure of analogs of ppp(A2'p)2A and (A2'p)2A with stability and biological activityD A Eppstein, Y V March, B B Schryver, et al.
Virology|June 15, 2007
Isolation and characterization of monoclonal antibodies elicited by trimeric HIV-1 Env gp140 protein immunogensNina R Derby, Sean Gray, Elizabeth Wayner, et al.
Journal of Virology|February 23, 2000
Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag geneJ zur Megede, M C Chen, B Doe, et al.
Journal of Virology|August 17, 2006
Antibody responses elicited in macaques immunized with human immunodeficiency virus type 1 (HIV-1) SF162-derived gp140 envelope immunogens: comparison with those elicited during homologous simian/human immunodeficiency virus SHIVSF162P4 and heterologous HIV-1 infectionNina R Derby, Zane Kraft, Elaine Kan, et al.
Vaccine|February 5, 2008
Characterization of immune responses elicited in mice by intranasal co-immunization with HIV-1 Tat, gp140 DeltaV2Env and/or SIV Gag proteins and the nontoxicogenic heat-labile Escherichia coli enterotoxinAntonella Caputo, Egidio Brocca-Cofano, Arianna Castaldello, et al.
Journal of Virology|August 14, 2003
Variability at human immunodeficiency virus type 1 subtype C protease cleavage sites: an indication of viral fitness?Tulio de Oliveira, Susan Engelbrecht, Estrelita Janse van Rensburg, et al.
Talanta|July 1, 2008
A screening test for heroin based on sequential injection analysis with dual-reagent chemiluminescence detectionLauren A Hill, Claire E Lenehan, Paul S Francis, et al.
Chemical Biology & Drug Design|February 18, 2009
Structural insights for design of potent spleen tyrosine kinase inhibitors from crystallographic analysis of three inhibitor complexesArmando G Villaseñor, Rama Kondru, Hoangdung Ho, et al.
Pageof 41